SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067112
Filing Date
2023-08-14
Accepted
2023-08-14 16:30:50
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_aditxt.htm   iXBRL 10-Q 1221146
2 CERTIFICATION f10q0623ex31-1_aditxt.htm EX-31.1 10333
3 CERTIFICATION f10q0623ex31-2_aditxt.htm EX-31.2 10212
4 CERTIFICATION f10q0623ex32-1_aditxt.htm EX-32.1 4894
  Complete submission text file 0001213900-23-067112.txt   5731515

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20230630.xsd EX-101.SCH 58790
6 XBRL CALCULATION FILE adtx-20230630_cal.xml EX-101.CAL 31473
7 XBRL DEFINITION FILE adtx-20230630_def.xml EX-101.DEF 262917
8 XBRL LABEL FILE adtx-20230630_lab.xml EX-101.LAB 548098
9 XBRL PRESENTATION FILE adtx-20230630_pre.xml EX-101.PRE 275485
55 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_aditxt_htm.xml XML 649227
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 231170952
SIC: 2834 Pharmaceutical Preparations